+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

From
From
From
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • April 2021
  • 2111 pages
CAS 50-18-0 Cyclophosphamide Chemical World Report - Product Thumbnail Image

CAS 50-18-0 Cyclophosphamide Chemical World Report

  • Report
  • April 2021
  • 2011 pages
CAS 15663-27-1 Cisplatin Chemical World Report - Product Thumbnail Image

CAS 15663-27-1 Cisplatin Chemical World Report

  • Report
  • April 2021
  • 2157 pages
CAS 159351-69-6 Everolimus Chemical World Report - Product Thumbnail Image

CAS 159351-69-6 Everolimus Chemical World Report

  • Report
  • April 2021
  • 2075 pages
CAS Methotrexate World Consumption Report - Product Thumbnail Image

CAS Methotrexate World Consumption Report

  • Report
  • April 2021
  • 2095 pages
CAS Cyclophosphamide World Consumption Report - Product Thumbnail Image

CAS Cyclophosphamide World Consumption Report

  • Report
  • April 2021
  • 2091 pages
From
From
From
Recurrent anaplastic astrocytomas - Pipeline Insight, 2021 - Product Thumbnail Image

Recurrent anaplastic astrocytomas - Pipeline Insight, 2021

  • Drug Pipelines
  • March 2021
  • 60 pages
From
Medulloblastoma - Pipeline Insight, 2021 - Product Thumbnail Image

Medulloblastoma - Pipeline Insight, 2021

  • Drug Pipelines
  • March 2021
  • 60 pages
From
Glioblastoma - Pipeline Insight, 2021 - Product Thumbnail Image

Glioblastoma - Pipeline Insight, 2021

  • Drug Pipelines
  • March 2021
  • 240 pages
From
Loading Indicator

With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more

adroll